Guided Therapeutics (GTHP) Short term Debt (2011 - 2025)
Guided Therapeutics recorded quarterly Short term Debt of $37000.0 in Q4 2025, down 53.16% quarter-over-quarter from $79000.0 in Q3 2025, and down 68.64% year-over-year from $118000.0 in Q4 2024.
Guided Therapeutics' Short term Debt history runs 13 years deep, the most recent figure standing at $37000.0 for Q4 2025.
- In Q4 2025, Short term Debt fell 68.64% year-over-year to $37000.0; the TTM figure through Dec 2025 stood at $37000.0 (down 68.64% YoY), while the FY2025 annual figure was $37000.0, down 68.64% from the prior year.
- Short term Debt came in at $37000.0 for Q4 2025 at Guided Therapeutics, down from $79000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.1 million in Q2 2024 to a low of $17000.0 in Q4 2022.
- A 4-year average of $211933.3 and a median of $60000.0 in 2025 frame the typical range for Short term Debt.
- Across the five-year window, Short term Debt soared 77.78% in 2022 and slumped 94.69% in 2025, its largest moves.
- Guided Therapeutics' Short term Debt stood at $88000.0 in 2021, then slumped by 80.68% to $17000.0 in 2022, then soared by 594.12% to $118000.0 in 2024, then sank by 68.64% to $37000.0 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $37000.0, $79000.0, and $60000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 308,000.00 |
| Mar 31, 2021 | 45,000.00 |
| Dec 31, 2020 | 328,000.00 |
| Sep 30, 2019 | 497,000.00 |
| Dec 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | 1.01 Mn |
| Sep 30, 2016 | 193,000.00 |
| Dec 31, 2015 | 133,000.00 |
| Mar 31, 2015 | 168,000.00 |
| Dec 31, 2014 | 123,000.00 |
| Sep 30, 2014 | 118,000.00 |
| Jun 30, 2014 | 160,000.00 |
| Mar 31, 2014 | 111,000.00 |
| Dec 31, 2013 | 109,000.00 |
| Sep 30, 2013 | 107,000.00 |
| Jun 30, 2013 | 101,000.00 |
| Mar 31, 2013 | 100,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Sep 30, 2012 | 11,000.00 |
| Jun 30, 2012 | 17,000.00 |
| Mar 31, 2012 | 24,000.00 |
| Dec 31, 2011 | 25,000.00 |
| Jun 30, 2011 | 24,000.00 |